Therapeutic strategies for diastolic dysfunction: a clinical perspective
1Division of Cardiology, Yonsei University College of Medicine, Seoul, Korea.
Journal of Cardiovascular Ultrasound
|July 28, 2010
Insights
Diastolic dysfunction, often unrecognized, significantly impacts heart failure prognosis. This review explores distinct therapeutic strategies for diastolic dysfunction and heart failure.
Area of Science:
- Cardiology
- Heart Failure Research
- Diastolic Function
Background:
- Diastolic dysfunction is a key factor in heart failure development and prognosis.
- It is frequently undiagnosed, leading to suboptimal patient outcomes.
- Therapeutic approaches differ significantly from those for systolic dysfunction.
Purpose of the Study:
- To review current therapeutic modalities for primary diastolic dysfunction.
- To discuss management strategies for heart failure with preserved ejection fraction.
- To highlight the distinct therapeutic implications of diastolic dysfunction.
Main Methods:
- Comprehensive literature review of pharmacologic, nonpharmacologic, and surgical interventions.
- Analysis of studies focusing on primary diastolic dysfunction.
- Synthesis of evidence regarding heart failure management.
Main Results:
- Various pharmacologic agents show potential in managing diastolic dysfunction.
- Nonpharmacologic strategies, including lifestyle modifications, are crucial.
- Surgical options are considered in specific refractory cases.
Conclusions:
- Effective management of diastolic dysfunction requires tailored therapeutic approaches.
- Early recognition and treatment are vital for improving heart failure prognosis.
- Further research is needed to optimize treatment strategies.
Abstract:
Diastolic dysfunction, which is increasingly viewed as being influential in precipitating heart failure and determining prognosis, is often unrecognized and has therapeutic implications distinct from those that occur with systolic dysfunction. In this review, several therapeutic modalities including pharmacologic, nonpharmacologic, and surgical approaches for primary diastolic dysfunction and heart failure will be discussed.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...